Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dibucaine
Drug ID BADD_D00651
Description A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
Indications and Usage For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Marketing Status approved; vet_approved
ATC Code S01HA06; D04AB02; C05AD04; N01BB06; S02DA04
DrugBank ID DB00527
KEGG ID D00733
MeSH ID D003992
PubChem ID 3025
TTD Drug ID D0P5GE
NDC Product Code 45802-050; 0536-1211; 81266-920; 71399-2829
UNII L6JW2TJG99
Synonyms Dibucaine | Cinchocaine | Sovcaine | Nupercaine | Cincain | Nupercainal
Chemical Information
Molecular Formula C20H29N3O2
CAS Registry Number 85-79-0
SMILES CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Haemorrhage24.07.01.002--Not Available
The 1th Page    1    Total 1 Pages